Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Tumor-Targeted IL-12 (PDS01ADC) with Hepatic Artery Infusion Pump Therapy for Colorectal Liver Metastases: Interim Analysis of a Non-randomized Phase II Trial.
Journal: JCO oncology advances
Published: April 06, 2026
Use of yttrium-90 radioembolization to control liver metastases in pancreatic acinar cell carcinoma and pancreatoblastoma: Two case reports.
Journal: World journal of gastroenterology
Published: September 08, 2025
Hepatic lymph node metastases in patients with colorectal liver metastases undergoing hepatic artery infusion pump placement.
Journal: Annals of hepato-biliary-pancreatic surgery
Published: August 12, 2025
Altering the gut microbiome and tumor microenvironment in advanced liver cancer: A phase II study of nivolumab, tadalafil and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorectal or pancreatic cancers.
Journal: Cancer letters
Published: May 27, 2025
Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers.
Journal: Frontiers in oncology
Published: February 14, 2024
Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma?
Journal: Journal of cancer metastasis and treatment
Published: August 04, 2023
Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma.
Journal: Cancers
Published: July 12, 2022
A phase II trial of the super-enhancer inhibitor Minnelide™ in advanced refractory adenosquamous carcinoma of the pancreas.
Journal: Future oncology (London, England)
Published: May 10, 2022
Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer Institute.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 09, 2022
Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironment.
Journal: Translational oncology
Published: February 24, 2022
Patterns of bevacizumab use in patients with glioblastoma: an online survey among experts in neuro-oncology.
Journal: Neuro-oncology practice
Published: April 08, 2020
Pneumocystis jirovecii prophylaxis in patients treated for high-grade gliomas: a survey among neuro-oncologists.
Journal: Neuro-oncology practice
Published: August 07, 2019
Last Updated: 09/26/2026